Rohto Pharmaceutical4527 
$24.41-2.16%24h
-2.16%24h
Global rank2561
Market cap$5.57B
Change 7d-
YTD Performance21.96%
SP500 benchmarkOutperform
P/E0.21
P/S3.33
Revenue$1.67B
Earnings$185.27M
Dividend yield-
Main Sector
Consumer Defensive
EPS for Rohto Pharmaceutical (4527)
Rohto Pharmaceutical has an EPS of $115.29. In 2022, the company made an earnings per share (EPS) of $92.34. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for 4527
-
Value:-
EPS history for Rohto Pharmaceutical from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | $115.29 | 24.85% |
| 2022 | $92.34 | 26.18% |
| 2021 | $73.18 | 8.65% |
| 2020 | $67.36 | - |
View the highest EPS stocks
